Labshake search
Citations for R&D Systems :
101 - 150 of 946 citations for Vertical Electrophoresis Cells since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... CH12 cells were subsequently stimulated with recombinant TGFβ (R&D systems), recombinant IL-4 (R&D systems) ...
-
bioRxiv - Bioengineering 2021Quote: ... MCF10A cells were treated with human recombinant TGFβ1 (R&D Systems) for 2 weeks.
-
bioRxiv - Immunology 2020Quote: ... cells were treated with 40 ng/mL RANKL (R&D Systems). Subsequently ...
-
bioRxiv - Physiology 2022Quote: ... Cells were thereafter lysed with Lysis Buffer #6 (R&D Systems) and assayed for the expression levels of phospho-ERK1 (T202/Y204)/ERK2 (T185/Y187 ...
-
bioRxiv - Molecular Biology 2022Quote: ... 50 ng/mL recombinant human stem cell factor (R&D systems), 3 IU/mL Epoetin-alfa (Amgen) ...
-
bioRxiv - Biophysics 2024Quote: ... NK cells were incubated overnight with IL-15 (R&D System) at final concentration of 10 ng/mL (IL-15 activated NK cells ...
-
bioRxiv - Cell Biology 2024Quote: ... supplemented with 50ng/ml Stem cell Factor (SCF, R&D Systems), 3U/ml EPO (Neocormon) ...
-
bioRxiv - Immunology 2024Quote: ... Cells were then stained with anti-Regnase-1 (R&D systems) or anti-Regnase-3 (Helmholtz Munich Monoclonal Antibody Core Facility ...
-
bioRxiv - Developmental Biology 2023Quote: ... cells were treated with 50 ng/ml BMP4 (R&D systems) for 48 hours and with 1 hour pulse of 50 ng/ml BMP4 (R&D systems) ...
-
bioRxiv - Cancer Biology 2023Quote: ... The cells were incubated with anti-ERBB3 (MAB3481, R&D systems) for 1 h on ice ...
-
bioRxiv - Cancer Biology 2023Quote: ... were cultured in endothelial cell growth media (ECM) (R&D systems) in tissue culture flasks ...
-
bioRxiv - Genetics 2023Quote: ... cells were treated with 40 ng/mL RANKL (R&D Systems). Subsequently ...
-
bioRxiv - Cancer Biology 2023Quote: Cells were lysed with lysis buffer 17 (R&D Systems; 895943) supplemented with protease cocktail (Fisher Scientific ...
-
bioRxiv - Cell Biology 2022Quote: ... cells were treated with TNFα (40 ng/mL, R&D systems recombinant bovine TNFα 2279-BT ...
-
bioRxiv - Immunology 2023Quote: ... cells were stimulated with UTPγS (100 µM, R&D Systems, 3279), or UTPγS plus AR-C 118925XX (20 µM ...
-
bioRxiv - Neuroscience 2023Quote: ... vascular cell adhesion molecule 1 (VCAM-1) (R&D systems, DY643), intercellular adhesion molecule 1 (ICAM-1 ...
-
bioRxiv - Cancer Biology 2023Quote: ... homogenized and digested in Cell Lysis Buffer #2 (R&D Systems) containing protease inhibitors on ice for 1 hour ...
-
bioRxiv - Neuroscience 2024Quote: ... cells were cultured on CultrexTM (R&D systems #3532-005-02) -coated 48-well or 96-well plates ...
-
bioRxiv - Neuroscience 2020Quote: ... Cells were labeled with IgM PE-O4 antibody (R&D Systems FAB1326P) at 10 μl/106 cells ...
-
bioRxiv - Cell Biology 2022Quote: ... Some cells were treated 0.01µg/ml recombinant human WNT3A (R&D Systems) as positive control ...
-
bioRxiv - Genetics 2020Quote: Cells were washed with Flow Cytometry Staining Buffer (FC001, R&D Systems) and then stained in 50ul of Staining Buffer for one hour on ice with the following conjugated antibodies multiplexed at the indicated dilutions ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with CHIR99021 (8 µM, R&D systems, #4423/10) in the STEMdiff APEL2 medium (Stem Cell Technologies ...
-
bioRxiv - Microbiology 2021Quote: Stocks of the cell death inhibitors Z-VAD-FMK (R&D Systems), GSK’963 (Selleck Chemicals) ...
-
bioRxiv - Bioengineering 2020Quote: ... Recombinant human Wnt7a (Chinese Hamster Ovary cell line-derived, R&D Systems) at a concentration of 50 ng/mL was used for the culture displayed on Supp.Fig.1.
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/ml glial cell-derived neurotrophic factor (GDNF, R&D Systems), 200 μM ascorbic acid (AA ...
-
bioRxiv - Cancer Biology 2021Quote: Cells were treated with rhTGFβ1 and rhTGFβ2 (R&D systems, Minneapolis, MN) 1 ng/ml each in complete media ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with 100 ng/ml recombinant WNT3A (R&D Systems).
-
bioRxiv - Cell Biology 2022Quote: ... The cells were incubated with phycoerythrin-conjugated streptavidin antibody (R&D Systems) diluted in FACS buffer for 30 min and then washed twice with FACS buffer ...
-
bioRxiv - Immunology 2022Quote: ... cell culture plates were coated with recombinant DLL4-FC (R&D systems) overnight at 4°C at 0.5 μg/mL prior to the addition of FLS and cytokines ...
-
bioRxiv - Cell Biology 2021Quote: ... or differentiated 10T1/2 cells were treated with LRG1 (R&D Systems) for 24 h and then treated with isoproterenol (Sigma ...
-
bioRxiv - Molecular Biology 2020Quote: ... cells were stimulated with 50ng/ml BMP2 (R&D Systems, #355-GMP). Inhibition of the BMP signalling pathway was achieved through addition of LDN193187 dihydrochloride (Tocris ...
-
bioRxiv - Molecular Biology 2020Quote: ... siG9a cells were treated with 100ng/ml of rDKK1 (R&D Systems) or 200nM of porcupine inhibitor LGK974 (Selleck Chemicals ...
-
bioRxiv - Bioengineering 2022Quote: ... cells were incubated with mouse anti-FAP (clone 427819, R&D Systems) at a final concentration of 5 μg/ml for 20 minutes at room temperature and washed with FACS buffer ...
-
bioRxiv - Pathology 2022Quote: ... MPT cells were treated with 20 ng/mL TNFα (R&D Systems) or 20 ng/mL IL-1β (R&D Systems ...
-
bioRxiv - Bioengineering 2019Quote: ... cells were stained with primary antibodies against SOX17 (R&D Systems AF1924) and FOXA2 (Abcam 108422 ...
-
bioRxiv - Developmental Biology 2019Quote: ... supplemented with 10 ng/mL stem cell factor (SCF; R&D Systems), 1 ng/mL IL3 ...
-
bioRxiv - Cell Biology 2019Quote: ... Cells were then stained with anti-human osteocalcin-PE (R&D Systems) in SAP buffer (HBSS with 0.1% saponin and 0.05% sodium azide) ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were treated with Trem2 antibody (R&D Systems, Minneapolis, MN, USA) with final concentration of 10 µg/ml ...
-
bioRxiv - Cancer Biology 2021Quote: Cells were lysed in ice-cold Lysis Buffer 6 (R&D systems) supplemented with 10 μL/mL of protease inhibitor cocktail ...
-
bioRxiv - Cell Biology 2020Quote: ... HUVEC was cultured in Endothelial Cell Growth Media (R&D SYSTEMS, CCM027). HL-60 cells were differentiated with 1.5% DMSO for 6 days ...
-
The G2-phase enriched lncRNA SNHG26 is necessary for proper cell cycle progression and proliferationbioRxiv - Molecular Biology 2021Quote: ... we performed TACS XTT Cell viability Assay (R&D Systems™, 4891025K). HaCaT cells with the repressing domain and the activating domains were transduced with target-specific lentiviral gRNAs or a non-target control gRNA ...
-
bioRxiv - Molecular Biology 2021Quote: We performed TACS XTT Cell viability Assay (R&D Systems™, 4891025K) to investigate how down- and upregulation of EPB41L4A-AS1 affected the viability ...
-
bioRxiv - Cancer Biology 2022Quote: ... Serum-starved cells were stimulated with human recombinant TGFβ1 (R&D Systems) for 16h.
-
bioRxiv - Cell Biology 2022Quote: ... Cells were then exposed to rhIL-11 (R&D systems, #218-IL) for 24 hours ...
-
bioRxiv - Cancer Biology 2023Quote: ... cell viability was measured by Resazurin (R&D Systems, Minneapolis, MN, USA) as described previously (20) ...
-
bioRxiv - Microbiology 2023Quote: ... cell monolayers were either pre-treated with IFN-β (R&D systems, 8499-IF-010 ...
-
bioRxiv - Immunology 2023Quote: ... stem cell factor (SCF) (23.9 ng/ml; R&D Systems, 255-SC), Flt3L (8.7 ng/ml ...
-
bioRxiv - Cell Biology 2023Quote: Mouse neural stem cells (mNSCs) were purchased from R&D systems (NSC002). The cells were grown in proliferative conditions in complete basal media ...
-
bioRxiv - Neuroscience 2024Quote: ... and 20 ng/mL human stem cell factor (hSCF) (R&D Systems). After 4 days ...
-
TAK1 operates at the primary cilium in non-canonical TGFB/BMP signaling to control heart developmentbioRxiv - Developmental Biology 2024Quote: ... The cells were then stimulated with TGFB1 (R&D Systems, #240-B) or BMP2 (R&D Systems ...